GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 10th May 2013 07:14

Afren: Westhouse Securities initiates with a target price of 160p and a buy recommendation.Ashmore Group: Credit Suisse raises target price from 375p to 440p upgrading from underperform to neutral.Barratt Developments: Citigroup increases target price from 245p to 315p leaving its neutral rating unchanged. Deutsche Bank shifts target price from 323p to 336p and reiterates a buy recommendation.British Sky Broadcasting Group: Bank of America cuts target price from 670p to 650p and reiterates an underperform rating.Britvic: Deutsche Bank raises target price from 425p to 460p and retains a hold recommendation.BT Group: Bank of America takes target price from 275p to 325p and upgrades to buy.Clarke T: Panmure Gordon moves target price from 40p to 58p and upgrades from hold to buy.Derwent London: Morgan Stanley increases target price from 2220p to 2450p and upgrades to overweight.e-Therapeutics: Panmure Gordon shifts target price from 72p to 67p keeping its buy recommendation.Experian: Citigroup raises target price from 1320p to 1410p and maintains a buy recommendation. Deutsche Bank downgrades to hold with a target price of 529p.Greencore: Investec shifts target price from 125p to 130p and maintains a buy recommendation. Panmure Gordon takes target price from 110p to 125p retaining its buy recommendation.Inchcape: HSBC Holdings initiates with a target price of 640p and an overweight rating.InterContinental Hotels Group: JP Morgan lowers target price from 1950p to 1920p and reiterates a neutral rating.London Mining: JP Morgan moves target price from 215p to 205p and maintains an overweight rating.Lonmin: Exane BNP lowers target price from 270p to 260p staying with its neutral rating.Morrison (Wm): Nomura ups target price from 270p to 310p keeping a neutral rating.National Grid: JP Morgan moves target price from 730p to 785p and retains a neutral rating.Ocado Group: Goldman Sachs upgrades to buy with its target price at 300p. Panmure Gordon raises target price from 50p to 130p, but still recommends selling.Portmeirion: Panmure Gordon takes target price from 657p to 694p reiterating its buy recommendation.Restaurant Group: Panmure Gordon increases target price from 435p to 560p and keeps a buy recommendation.Rightmove: Panmure Gordon ups target price from 2000p to 2300p and leaves its buy recommendation unchanged.RPC Group: JP Morgan reduces target price from 512p to 491p and stays with its overweight rating.Sage Group: Exane BNP shifts target price from 235p to 240p and leaves its underperform rating unaltered.SIG: JP Morgan raises target price from 95p to 135p, while maintaining an underweight rating.St Modwen Properties: JP Morgan increases target price from 290p to 320p staying with its overweight rating.Travis Perkins: JP Morgan ups target price from 999p to 1380p, while its neutral rating remains unchanged. Panmure Gordon downgrades from buy to hold with a target price of 1350p.TUI Travel: Numis ups target price from 350p to 375p and reiterates an add rating. Panmure Gordon moves target price from 303p to 315p, while its hold recommendation is reiterated.Restaurant Group: Citigroup downgrades to neutral with a target price of 500p.Royal Bank of Scotland: Citigroup lowers target price from 300p to 290p keeping a neutral rating.Wetherspoon (JD): Deutsche Bank takes target price from 490p to 520p and maintains a hold recommendation. Panmure Gordon increases target price from 615p to 738p retaining a buy recommendation.
More News
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
21 May 2015 08:23

e-Therapeutics Says First Patient Enrolled In Phase Ib ETS2101 Trial

Read more
31 Mar 2015 08:21

e-Therapeutics Loss Widens As It Increases Development Spending

Read more
26 Feb 2015 14:12

e-Therapeutics Believes Drug Discovery Process Producing Higher Yield

Read more
23 Jan 2015 13:36

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Read more
21 Jan 2015 11:42

DIRECTOR DEALINGS: e-Therapeutics Finance Director Buys 150,000 Shares

Read more
16 Oct 2014 07:40

E-Therapeutics Appoints Sean Nicholson As Executive Director

Read more
16 Sep 2014 09:08

e-Therapeutics Loss Widens On Pipeline Development; Chair To Retire

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
4 Jul 2014 16:30

Daily Mail General Trust's Chairman sells £15.91m-worth of shares

Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or

Read more
4 Jul 2014 08:59

DIRECTOR DEALINGS: e-Therapeutics Finance Chief Buys 100,000 Shares

Read more
25 Jun 2014 16:02

DIRECTOR DEALINGS: e-Therapeutics Non-Executives Allotted New Shares

Read more
12 May 2014 11:49

e-Therapeutics Loss Widens As It Continues Pipeline Development

LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e

Read more
8 May 2014 13:30

UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures

LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians

Read more
8 May 2014 12:23

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.